Pazopanib Hydrochloride Followed By Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma
Conditions:  Adult Angiosarcoma;  Adult Desmoplastic Small Round Cell Tumor;  Adult Epithelioid Hemangioendothelioma;  Adult Epithelioid Sarcoma;  Adult Extraskeletal Chondrosarcoma;  Adult Fibrosarcoma;  Adult Leiomyosarcoma;  Adult Liposarcoma;  Adult Malignant Fibrous Histiocytoma;  Adult Malignant Hemangiopericytoma;  Adult Malignant Mesenchymoma;  Adult Neurofibrosarcoma;  Adult Synovial Sarcoma;  Dermatofibrosarcoma Protuberans;  Stage IIA Adult Soft Tissue Sarcoma;  Stage III Adult Soft Tissue Sarcoma;  Stage IV Adult Soft Tissue SarcomaInterventions:  Drug: pazopanib hydrochloride;  Drug: doxorubicin hydrochloride;  Drug: ifosfamide;  Other: placebo;  Procedure: therapeutic conventional surgery;  Radiation: external beam radiation therapy;  Other: pharmacological study;  Other: laboratory biomarker analysisSponsors:  University of Washington;  National Cancer Institute (NCI)Recruiting - verified January 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Angiosarcoma | Cancer & Oncology | Chemotherapy | Chondrosarcoma | Dermatology | Fibrosarcoma | Fibrous Histiocytoma | Hemangioendothelioma | Leiomyosarcoma | Liposarcoma | Neurology | Neurosurgery | Research | Sarcomas | Soft Tissue Sarcoma | Study | Synovial Sarcoma